Table 4.
Analyte | GS-9851 treatment (mg) | Accumulation, GLSMa |
90% CI | ||
---|---|---|---|---|---|
Test | Reference | Ratio | |||
GS-9851 | Overall | 74.99 | 79.44 | 0.94 | 0.63, 1.41 |
50 | 26.45 | 38.60 | 0.69 | 0.33, 1.41 | |
100 | 73.46 | 46.96 | 1.56 | 0. 53, 4.63 | |
200 | 114.65 | 115.14 | 1.00 | 0.48, 2.08 | |
400 | 141.93 | 190.80 | 0.74 | 0.34, 1.62 | |
GS-566500 | Overall | 51.40 | 68.16 | 0.75 | 0.45, 1.28 |
50 | 17.98 | 16.86 | 1.07 | 0.40, 2.83 | |
100 | 49.08 | 74.12 | 0.66 | 0.21, 2.13 | |
200 | 57.13 | 83.44 | 0.68 | 0.22, 2.17 | |
400 | 138.44 | 206.94 | 0.67 | 0.25, 1.82 | |
GS-331007 | Overall | 1,909.48 | 1,584.03 | 1.21 | 1.01, 1.45 |
50 | 851.38 | 863.61 | 0.99 | 0.61, 1.60 | |
100 | 1,685.25 | 1,136.42 | 1.48 | 1.03, 2.13 | |
200 | 2,797.72 | 2,418.59 | 1.16 | 0.85, 1.57 | |
400 | 3,311.80 | 2,652.34 | 1.25 | 0.86, 1.81 |
Geometric least-squares mean.